Ashton Thomas Private Wealth LLC increased its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 5.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,452 shares of the company’s stock after buying an additional 863 shares during the period. Ashton Thomas Private Wealth LLC’s holdings in Colgate-Palmolive were worth $1,405,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently bought and sold shares of the business. Callan Family Office LLC bought a new position in Colgate-Palmolive in the 4th quarter worth approximately $614,000. EagleClaw Capital Managment LLC boosted its holdings in Colgate-Palmolive by 6.2% in the 4th quarter. EagleClaw Capital Managment LLC now owns 34,914 shares of the company’s stock valued at $3,174,000 after purchasing an additional 2,035 shares during the period. Candriam S.C.A. boosted its holdings in Colgate-Palmolive by 26.0% in the 4th quarter. Candriam S.C.A. now owns 349,673 shares of the company’s stock valued at $31,789,000 after purchasing an additional 72,175 shares during the period. Freestone Capital Holdings LLC boosted its holdings in Colgate-Palmolive by 2.8% in the 4th quarter. Freestone Capital Holdings LLC now owns 42,186 shares of the company’s stock valued at $3,835,000 after purchasing an additional 1,166 shares during the period. Finally, Raymond James Financial Inc. bought a new position in Colgate-Palmolive in the 4th quarter valued at $132,405,000. 80.41% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several brokerages have commented on CL. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday, March 3rd. Stifel Nicolaus cut their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Piper Sandler cut their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. Barclays cut their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus target price of $101.61.
Colgate-Palmolive Price Performance
Shares of NYSE:CL opened at $96.84 on Friday. The stock has a market cap of $78.59 billion, a PE ratio of 27.51, a PEG ratio of 4.20 and a beta of 0.40. The company’s fifty day moving average is $88.84 and its 200 day moving average is $95.17. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the firm posted $0.87 EPS. Research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.
Colgate-Palmolive Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- What Are Dividend Achievers? An Introduction
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- Most Volatile Stocks, What Investors Need to Know
- 3 Stocks to Buy While Others Stay on the Sidelines
- Stock Splits, Do They Really Impact Investors?
- MarketBeat Week in Review – 03/03 – 03/07
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.